The state of the barrier function of the oral cavity of patients with a history of acute respiratory disease of COVID-19
Abstract
ABSTRACT. The entrance gate for the SARS-CoV virus is the system of mucous membranes of the upper respiratory tract and oral cavity, which creates the first line of defense of the body against the invasion of foreign agents. Objective to the study is the nature of insemination of the oral mucosa, the density of bacterial population and the adsorption capacity of the buccal epithelium in the post-covid period. Materials and methods. 162 patients who suffered acute respiratory disease of COVID-19 took part in the study, including 54 people. - light form, 69 people. - of medium difficulty and 39 persons. - heavy form. The control group consisted of 30 healthy patients. The clinical and laboratory examination was conducted on the basis of the dental department of the University Hospital of Ternopil during 2020-2022. The results. In patients with a history of a mild form of COVID-19, there is only a quantitative increase in the autochthonous microflora. The colonization index of the buccal epithelium is lower (1.54±0.09) um. units, than in patients of the control group. In patients with a medium-severe form, there are qualitative and quantitative changes in the microflora of the oral cavity, pathogenic and opportunistic microorganisms are often released in large quantities. The colonization index decreases to 1.23±0.01 um. With a severe form of COVID-19, significant changes in the microecology of the mucous membrane are observed - a decrease in the colonization index to 0.57 units. and significant deviations in the character of the microflora, a feature of which was the presence of associations of pathogenic microorganisms. Significant disturbances in the microecology of the mucous membrane of the oral cavity, the development of grade III-IV dysbacteriosis are signs of a significant decrease in the protective barrier properties of the mucous membrane. Conclusions. The intensive growth of pathogenic and conditionally pathogenic non-resident microorganisms is accompanied by the growth of "quorum sensing", which stimulates the manifestation of their pathogenic properties and reduces the barrier function of the mucous membrane of the oral cavity. The obtained results of the assessment of the state of the barrier function of the oral mucosa, the detected violations in the colonization resistance of the oral mucosa of the post-covid syndrome dictate the need to develop and implement in clinical practice an algorithm for the examination of a dental patient with post-covid syndrome.
Downloads
References
Postanova Kabinet Ministriv Ukrainy vid 20 travnia 2020 r. № 392 «Pro vstanovlennia karantynu z metoiu zapobihannia poshyrenniu na terytorii Ukrainy hostroi respiratornoi khvoroby COVID-19, sprychynenoi koronavirusom SARS-CoV-2, ta etapiv poslablennia protyepidemichnykh zakhodiv». [in Ukrainian]. Available: https://zakon.rada.gov.ua/laws/show/392-2020-%D0%BF#Text.
Lau SK, Woo PC, Huang KY, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Natl Acad Sci. 2005;102(39):14040-5. DOI: https://doi.org/10.1073/pnas.0506735102
Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of a new coronavirus from a person with pneumonia in Saudi Arabiа. N Engl J Med. 2012;367(19):1814-20. DOI: https://doi.org/10.1056/NEJMoa1211721
Perlman S. Another decade, another coronavirus. N. Engl. J. Med. 2020;382(8):760-2. DOI: https://doi.org/10.1056/NEJMe2001126
Hui DS, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin. 2019;33(4):869-89. DOI: https://doi.org/10.1016/j.idc.2019.07.001
WHO. Coronavirus disease (COVID-19) pandemic. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. J. Austral. Acad. Critical Care Med., 2020;22(2):95-7. Available: https://pubmed.ncbi.nlm.nih.gov/32294809/
Hudarian AA, Mashchenko YS, Shandыba SY. Heneralyzovannыi parodontyt u bolnыkh sakharnыm dyabetom 2 typa. Lambert Akademic Publishing. Dnepr. 2020;157 s. [in Ukrainian]. Available: https://repo.dma.dp.ua/4061/2/МОНОГРАФИЯ%20Гударьян.pdf
Boichenko OM. Stan mikrotsyrkuliatsii ta rehionarnoi hemodynamiky tkanyn parodonta pry khronichnomu heneralizovanomu parodontyti u khvorykh na ishemichnu khvorobu sertsia. Aktualni problemy suchasnoi medytsyny. 2015;15-4(52):5-11. [in Ukrainian]. Available: http://nbuv.gov.ua/UJRN/apsm_2015_15_4_2
Onyshchenko VS, Ovcharenko OM, Doroshenko OM, ta in. Osoblyvosti pokaznykiv mikrotsyrkuliatsii klinichno zdorovykh tkanyn parodonta ta pry parodontytakh riznoho stupenia tiazhkosti za danymy LDF //Mat. konf. «UZD neotlozhnыkh sostoianyi», Sudak, 2007. [in Ukrainian]. Available: http://ultrasound.net.ua/materiali/materialii-konferencii-ta-zjizdiv/sudak-2007-uzd-neotlozhnykh-sostojanii/osoblivosti-pokaznikiv-mikrocirkuljaciji-klinichno-zdorovikh-tkanin-parodonta-ta-pri-parodontitakh-riznogo-stupenja-tjazhkosti-za-danimi-ldf/
The Scottish Dental Clinical Effectiveness Programme (SDCEP). Rapid Review of Aerosol Generating Procedures in Dentistry. Published 2020-2021. Available: https://www.sdcep.org.uk/published-guidance/covid-19-practice-recovery/rapid-review-of-agps/
WHO-convened Global Study of Origins of SARS-CoV-2: China Part Joint WHO-China Study 14 January-10 February 2021. Joint Report. Available: https://www.who.int/publications/i/item/who-convened-global-study-of-origins-of-sars-cov-2-china-part
Swaminathan Y., Thomas T., Muralidharan J. The efficacy of preprocedural mouth rinse of 0.2percent chlorhexidine and commercially available herbal mouth rinse containing salvadora persica in reducing the bacterial load in saliva and aerosol produced during scaling. Asian J Pharm Clin Res. 2014;7:71-4. Available: https://innovareacademics.in/journals/index.php/ajpcr/article/view/798
Nibali L, Ide M, Ng D, Buontempo Z, Clayton Y, Asimakopoulou K. The perceived impact of Covid-19 on periodontal practice in the United Kingdom: A questionnaire study. J Dent. 2020;102:103481. DOI: https://doi.org/10.1016/j.jdent.2020.103481
Tolly W. Protecting our Health Our response in Wales to the first phase of COVID-19 Chief Medical Officer for Wales SPECIAL REPORT. The standard surgical procedure for dental treatment of patients other than COVID-19 is in Wales. Available: https://www.gov.wales/sites/default/files/publications/2021-01/chief-medical-officer-for-wales-special-report.pdf
Sadun AS, Taiyeb-Ali TB, Fathilah AR, Himratul-Aznita WH, Saub R. Effectiveness of Pre-Procedural Rinsing with Essential Oils-Based Mouthrinse to Reduce Aerosol Contamination of Periodontitis Patients. Sains Malaysiana. 2020;49:139-43. DOI: https://doi.org/10.17576/jsm-2020-4901-17
Santosh TS, Parmar R, Anand H, Srikanth K. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19. 2020;17;12(4):e7708. DOI: https://doi.org/10.7759/cureus.7708
Johnson IG, Jones RJ, Gallagher JE., Wade WG, Al-Yaseen W, Robertson M, McGregor S, et al. Dental periodontal procedures: a systematic review of contamination (splatter, droplets and aerosol) in relation to COVID-19. DOI: https://doi.org/10.1038/s41405-021-00070-9
Takefuji Y. COVID and perio. Br Dent J. 2023;234:197. DOI: https://doi.org/10.1038/s41415-023-5585-3
Baima G, Marruganti C, Sanz M, Aimetti M, Romandini M. Periodontitis and COVID-19: biological mechanisms and meta-analyses of epidemiological evidence. J Dent Res 2022;101:1430-1440. DOI: https://doi.org/10.1177/00220345221104725
Marouf N, Cai W, Said K N, et al. Association between periodontitis and severity of COVID-19 infection: A case-control study. J Clin Periodontol 2021;48:483-491. DOI: https://doi.org/10.1111/jcpe.13435
Tamimi F, Altigani S, Sanz M. Periodontitis and coronavirus disease 2019. Periodontol 2000. 2022;89:207-214. DOI: https://doi.org/10.1111/prd.12434
Mishra S, Gupta V, Rahman W, Gazala MP, Anil S. Association between periodontitis and COVID-19 based on severity scores of HRCT chest scans. Dent J Basel 2022; DOI: https://doi.org/10.3390/dj1006010
Shamsoddin E. Is periodontitis associated with the severity of COVID-19? Evid Based Dent 2021; 22: 66-68. DOI: https://doi.org/10.1038/s41432-021-0179-x
Savychuk NO, Trubka IA, Rossokha ZI, Kyriachenko SP. Kolonizatsiina rezystentnist porozhnyny rota. Ukr.med.chasopys. 2018;3(125):V-VI. [in Ukrainian]. Available: https://www.umj.com.ua/article/39590/kolonizacijna-rezistentnist-porozhnini-rota
Living with COVID-19: A dynamic review of the evidence around ongoing COVID-19 symptoms (often called long COVID). National Institute for Health Research. https://evidence.nihr.ac.uk/themedreview/living-with-covid19. Accessed Nov. 10, 2020.
Post-COVID conditions: Information for healthcare providers. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. Accessed Oct. 20, 2021.
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. DOI: https://doi.org/10.1016/j.cmi.2020.07.016
Stanford University Global Systematic Review (2021). Режим доступу: https://med.stanford.edu/covid19/research.html
Hevkaliuk NO, Sydliaruk NY, Pynda MIa, Pudiak VE, Krupei VIa. Sostoianye nespetsyfycheskoi rezystentnosty slyzystoi obolochky polosty rta pry hryppoznom stomatyte u detei v kontseptsyy obshchnosty MALT-systemы. Georgian Medical News, 2018;7-8 (280-281:34-40.
Langalia A, Sinha N, Thakker V, Shah A, Shah J, Singh B. Saliva as a propitious diagnostic biofluid, biomarker, and bodies first line of defense against COVID-19: A review. J Family Med Prim Care, 2022;11(6):2292-2301. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1567_21
Azzi L, Maurino V, Baj A, Dani M, d'Aiuto A, Fasano M, Lualdi M, Sessa F, Alberio T. Diagnostic salivary tests for SARS-CoV-2. J Dent Res, 2021;100(2):115-123. DOI: https://doi.org/10.1177/0022034520969670
Desai S, Mishra SV, Joshi A, Sarkar D, Hole A, Mishra R, Dutt S, Chilakapati MK, Gupta S, Dutt A. Raman spectroscopy-based detection of RNA viruses n saliva: A preliminary report. J Biophotonics. 2020;13(10):e202000189. DOI: https://doi.org/10.1002/jbio.202000189
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 2020;28;71(15):762-768. DOI: https://doi.org/10.1093/cid/ciaa248
Langalia A, Sinha N, Thakker V, Shah A, Shah J, Singh B. Saliva as a propitious diagnostic biofluid, biomarker, and bodies first line of defense against COVID-19: A review. J Family Med Prim Care, 2022;11(6):2292-2301. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1567_21
Zhang W, Qin C, Fei Y, Shen M, Zhou Y, Zhang Y, Zeng X, Zhang S. Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update. Clin Immunol, 2022;239:109022. DOI: https://doi.org/10.1016/j.clim.2022.109022
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ. et al. Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ. Res, 2020;8. DOI: https://doi.org/10.1161/CIRCRESAHA.120.317015
Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension. 2020;25. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15082
Zastosuvannya likiv pry COVID-19. Spetsproekt Derzhavnoho ekspertnoho tsentru MOZ. [The use of drugs in COVID-19. Special project of the State Expert Center of the Ministry of Health]. Retrieved from http://covid19.dec.gov.ua
Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. NICE Evidence review. https://www.nice.org.uk/advice/es23/evidence/evidence-review-pdf-8717218669
Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M. Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. J Clin Med, 2019;8(6):786. DOI: https://doi.org/10.3390/jcm8060786
Li K, Huang B, Wu M et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020;11:6044. DOI: https://doi.org/10.1038/s41467-020-19943-y
Sohn Y, Jeong SJ, Chung WS, Hyun JH, Baek YJ, Cho Y, Kim JH, Ahn JY, Choi JY, Yeom JS. Assessing viral shedding and infectivity of asymptomatic or mildly symptomatic patients with COVID-19 in a later phase. J Clin Med. 2020;9(9):2924. DOI: https://doi.org/10.3390/jcm9092924
Hossain MM, Das J, Rahman F, Nesa F, Hossain P, Islam AMK, Tasnim S, Faizah F, Mazumder H, Purohit N, Ramirez G. Living with "long COVID": A systematic review and meta-synthesis of qualitative evidence. PLoS One. 2023;18(2):e0281884. DOI: https://doi.org/10.1371/journal.pone.0281884
